CSF complements serum for evaluating paraneoplastic antibodies and NMO-IgG

Neurology

Volumn 76, Issue 12, 2011, Pages 1108-1110

  McKeon, Andrew ^a   Pittock, Sean J ^a   Lennon, Vanda A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR ANTIBODY; PARANEOPLASTIC ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; BLOOD ANALYSIS; CEREBROSPINAL FLUID ANALYSIS; DRUG CEREBROSPINAL FLUID LEVEL; HUMAN; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; MYELOOPTIC NEUROPATHY; PRIORITY JOURNAL;

AUTOANTIBODIES; HUMANS; IMMUNOGLOBULIN G; NEUROMYELITIS OPTICA; PARANEOPLASTIC SYNDROMES;

EID: 79953207375     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e318211c379     Document Type: Article

References (6)

1. Pittock SJ, Kryzer TJ, Lennon VA. Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome. Ann Neurol 2004;56:715-719. (Pubitemid 39540753)
2. Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004;364: 2106-2112. (Pubitemid 39626806)
3. Kumar MA, Jain A, Dechant VE, et al. Anti-N-methyl-Daspartate receptor encephalitis during pregnancy. Arch Neurol 2010;67:884-887.
4. Klawiter EC, Alvarez E 3rd, Xu J, et al. NMO-IgG detected in CSF in seronegative neuromyelitis optica. Neurology 2009;72:1101-1103.
5. McKeon A, Apiwattanakul M, Lachance DH, et al. Positron emission tomography-computed tomography in paraneoplastic neurologic disorders: systematic analysis and review. Arch Neurol 2010;67:322-329.
6. Dalmau J, Gleichman AJ, Hughes EG, et al. Anti-NMDAreceptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008;7:1091-1098.